How have we gotten to the point where, in many parts of the country, fatal overdoses from narcotics are three times the rate of suicides?
On August 10, at 2 p.m. PDT, NAMI’s Ask the Doctor Webinar will explore this question and many more, as we take an
in-depth look at America’s opioid epidemic with Dr. Suzanne Vogel-Scibilia. An expert in the field, Dr. Vogel-Scibilia will walk through the epidemic’s historical background; relevant,
pressing policy matters; options for systemic change; as well as treatment options for substance abuse disorders, especially those with opioid use disorder. Her talk will be followed by a
Q&A, led by Dr. Ken Duckworth, NAMI’s Medical Director.
Ask The Doctor: “Ketamine For Depression: Progress And Pitfalls” With Dr. Cristina Cusin, M.D.
May. 15, 2017
NAMI Ask The Doctor: “Ketamine for Depression: Progress and Pitfalls” with Dr. Cristina Cusin, M.D.
Dr. Cusin addresses Ketamine,* an anesthetic drug that in very small doses has been shown to relieve symptoms of depression within hours—even in patients who did not improve with other
treatments. In this presentation, we briefly review the literature from clinical trials supporting the efficacy of ketamine for patients with Major Depressive Disorder and Bipolar Depression. We
then review the numerous limitations of current knowledge and future lines of research on the effects of ketamine. An interactive Q&A follows.
Dr. Cristina Cusin is the Director of Translational Studies in Depression at MGH and is Assistant Professor in
Psychiatry at Harvard Medical School. She is originally from Milan, Italy where she obtained her Medical Degree and after moving to U.S. she completed the residency program in Psychiatry at
MGH/McLean in Boston.
Dr. Cusin's clinical and research interests are focused on the most severe and difficult to treat forms of depression. She performs consultations for patients with treatment-resistant depression
and bipolar disorder. She has specific expertise in psychopharmacology and in device-based therapies including ECT, VNS, DBS. She is the Director of the MGH Ketamine clinic for
treatment-resistant depression and she is the primary investigator in research studies on the use of ketamine at MGH.
* Please note that Ketamine has not been approved by the FDA for the treatment of depression
Ask the Doctor: “Understanding and Helping Kids with Social, Emotional and Behavioral Challenges” with Dr. Ross Greene
Feb. 17, 2017
NAMI Ask The Doctor presents Dr. Ross Greene and “Understanding and Helping Kids with Social, Emotional and Behavioral Challenges.”
In this webinar, Dr. Greene discusses innovative strategies from his Collaborative & Proactive Solutions model for working with behaviorally challenging kids. This model includes how to
collaborate with children to proactively solve problems, as well as how to teach foundational behavioral skills such as frustration tolerance, flexibility/adaptability and problem-solving.
Dr. Greene is the author of several influential books including the recently released, Raising Human Beings.
Ask The Doctor: “I Am Not Sick, I Don’t Need Help!” With Dr. Xavier Amador
Nov. 03, 2016
Learn why some people living with mental illness believe they don't need help or see obvious symptoms, and how this can become an obstacle to helping them get help.
Dr. Amador will share information on overcoming this common obstacle using LEAP—Listen, Empathize, Agree and Partner. With LEAP, a person can quickly gain trust, lower anger and tension,
develop genuine understanding and empathy making it possible to partner with a loved one and help them receive treatment.
Dr. Xavier Amador is an internationally renowned clinical psychologist and leader in his field. He is the author of many popular books include IAm Not Sick, I Don’t Need Help about the LEAP method to
overcome lack of insight into mental illness. It has been helping families help loved ones for years.
NOTE: We’re sorry. At the presenter’s request, the recorded webinar does not contain the previously included short video.
Ask The Doctor: Early Psychosis Treatment With Dr. Lisa Dixon
Sep. 14, 2016
Learn about exciting new research findings that point to better outcomes and maximized recovery when young people receive treatment during early psychosis from presenter, Dr. Lisa Dixon.
Dr. Dixon is the principle investigator on the NIMH Recovery After Initial Schizophrenia Episode-Implementation and Evaluation (RAISE-IES) study and spearheading new advancements in treatment of
early psychosis. She continues to work on increasing access to innovative programs designed to improve outcomes for people experiencing their first episode of psychosis.